dr. leslie on sequencing zanubrutinib in mcl
Published 3 years ago • 121 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
0:58
dr. leslie on the benefits with zanubrutinib in mcl
-
1:29
dr. leslie on the role of zanubrutinib in mcl
-
0:47
lori leslie, md, considers the use of zanubrutinib in relapsed/refractory mantle cell lymphoma
-
1:48
dr. leslie on the current frontline treatment landscape in mcl
-
1:08
dr. song on zanubrutinib activity in relapsed/refractory mcl
-
4:51
so it begins... brukinsa... zanubrutinib
-
11:13
understanding mantle cell lymphoma
-
38:45
nobel lecture: charles m. rice, nobel prize in physiology or medicine 2020
-
1:40
dr. leslie on real-world outcomes of patients with cll treated with acalabrutinib
-
1:13
dr. leslie on remaining questions address in mcl
-
1:10
dr. wang on the toxicity of ibrutinib, acalabrutinib, and zanubrutinib in mcl
-
0:59
dr. rule on the fda approval of zanubrutinib in mcl
-
1:26
dr. patel discusses zanubrutinib in mcl
-
5:00
beigene’s brukinsa (zanubrutinib): a newly approved treatment medicine for mantle cell lymphoma (mcl
-
0:44
dr. tam on zanubrutinib approval in mcl
-
1:46
dr. shah discusses sequencing for mcl
-
1:32
dr. zelenetz on zanubrutinib research in mcl
-
1:02
dr. tam on zanubrutinib vs ibrutinib research in mantle cell lymphoma
-
2:23
yuqin song | ash 18 | zanubrutinib (bgb-3111) in relapsed/refractory mantle cell lymphoma
-
1:39
dr. ghosh on global trials with zanubrutinib in mcl and nhl
-
1:42
zanubrutinib plus rituximab in first-line mcl therapy
-
1:22
michael wang, md, on the distinct advantages of zanubrutinib in the management of lymphoma